Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2004-4-6
pubmed:databankReference
pubmed:abstractText
Inhibitory and activatory C-type lectin-like receptors play an important role in immunity through the regulation of leukocytes. Here, we report the identification and characterization of a novel myeloid inhibitory C-type lectin-like receptor (MICL) whose expression is primarily restricted to granulocytes and monocytes. This receptor, which contains a single C-type lectin-like domain and a cytoplasmic immunoreceptor tyrosine-based inhibitory motif, is related to LOX-1 (lectin-like receptor for oxidized low density lipoprotein-1) and the beta-glucan receptor (Dectin-1) and is variably spliced and highly N-glycosylated. We demonstrate that it preferentially associates with the signaling phosphatases SHP-1 and SHP-2, but not with SHIP. Novel chimeric analyses with a construct combining MICL and the beta-glucan receptor show that MICL can inhibit cellular activation through its cytoplasmic immunoreceptor tyrosine-based inhibitory motif. These data suggest that MICL is a negative regulator of granulocyte and monocyte function.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
9
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14792-802
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14739280-Alternative Splicing, pubmed-meshheading:14739280-Amino Acid Motifs, pubmed-meshheading:14739280-Amino Acid Sequence, pubmed-meshheading:14739280-Animals, pubmed-meshheading:14739280-Base Sequence, pubmed-meshheading:14739280-Blotting, Northern, pubmed-meshheading:14739280-CHO Cells, pubmed-meshheading:14739280-Cell Line, pubmed-meshheading:14739280-Cloning, Molecular, pubmed-meshheading:14739280-Cricetinae, pubmed-meshheading:14739280-Cytoplasm, pubmed-meshheading:14739280-Glycosylation, pubmed-meshheading:14739280-Granulocytes, pubmed-meshheading:14739280-Humans, pubmed-meshheading:14739280-Lectins, C-Type, pubmed-meshheading:14739280-Mice, pubmed-meshheading:14739280-Models, Biological, pubmed-meshheading:14739280-Molecular Sequence Data, pubmed-meshheading:14739280-Monocytes, pubmed-meshheading:14739280-NIH 3T3 Cells, pubmed-meshheading:14739280-Phylogeny, pubmed-meshheading:14739280-Precipitin Tests, pubmed-meshheading:14739280-Protein Binding, pubmed-meshheading:14739280-Protein Structure, Tertiary, pubmed-meshheading:14739280-RNA, pubmed-meshheading:14739280-RNA, Messenger, pubmed-meshheading:14739280-Rats, pubmed-meshheading:14739280-Receptors, LDL, pubmed-meshheading:14739280-Receptors, Mitogen, pubmed-meshheading:14739280-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14739280-Sequence Homology, Amino Acid, pubmed-meshheading:14739280-Signal Transduction, pubmed-meshheading:14739280-Spectrometry, Fluorescence, pubmed-meshheading:14739280-Tissue Distribution, pubmed-meshheading:14739280-Transfection, pubmed-meshheading:14739280-Tumor Necrosis Factor-alpha
pubmed:year
2004
pubmed:articleTitle
Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes.
pubmed:affiliation
Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't